Advisory Board October 17, 2022

President Joe Biden on Friday signed an executive order directing HHS Secretary Xavier Becerra to explore new health care payment and delivery models through the Center for Medicare and Medicaid Innovation (CMMI) that could lead to lower drug costs.

Details on the order

As part of the executive order, Becerra will have 90 days to submit a report outlining “new health care payment and delivery models that would lower drug costs and promote access to innovative drug therapies for beneficiaries enrolled in the Medicare and Medicaid programs, including models that may lead to lower cost-sharing for commonly used drugs and support value-based payment that promotes high-quality care.”

Becerra’s report will include his plan and timeline to test any potential models...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, HHS, Insurance, Medicare, Pharma, Pharma / Biotech
Trump’s New AI Czar: Game-Changer Or A Pandora’s Box?
What a Trump presidency could mean for ASCs: 4 leaders weigh in
How 'Make America Healthy Again' May Have Found Its Moment
Mercy takes to Capitol Hill on AI
Shorter surgeon wait times, fewer ED visits: 11 Biden Cancer Moonshot updates

Share This Article